ID   MTMR6_HUMAN             Reviewed;         621 AA.
AC   Q9Y217; B2RBB5; B3KSB4; Q5JRG6; Q86TB7; Q86YH4; Q96P80;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   15-MAR-2017, entry version 159.
DE   RecName: Full=Myotubularin-related protein 6;
DE            EC=3.1.3.-;
GN   Name=MTMR6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INTERACTION WITH MTMR9.
RX   PubMed=12890864; DOI=10.1073/pnas.1333958100;
RA   Mochizuki Y., Majerus P.W.;
RT   "Characterization of myotubularin-related protein 7 and its binding
RT   partner, myotubularin-related protein 9.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:9768-9773(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-319.
RA   Hong W.;
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   VAL-319.
RC   TISSUE=Testis, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-319.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E.,
RA   Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T.,
RA   Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R.,
RA   Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S.,
RA   Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M.,
RA   Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J.,
RA   Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E.,
RA   Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L.,
RA   Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J.,
RA   Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S.,
RA   Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J.,
RA   Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M.,
RA   King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A.,
RA   Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S.,
RA   Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S.,
RA   Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A.,
RA   Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L.,
RA   Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M.,
RA   Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-319.
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 157-621 (ISOFORM 1), AND VARIANT
RP   VAL-319.
RX   PubMed=9736772; DOI=10.1093/hmg/7.11.1703;
RA   Laporte J., Blondeau F., Buj-Bello A., Tentler D., Kretz C., Dahl N.,
RA   Mandel J.-L.;
RT   "Characterization of the myotubularin dual specificity phosphatase
RT   gene family from yeast to human.";
RL   Hum. Mol. Genet. 7:1703-1712(1998).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH KCNN4.
RX   PubMed=15831468; DOI=10.1128/MCB.25.9.3630-3638.2005;
RA   Srivastava S., Li Z., Lin L., Liu G., Ko K., Coetzee W.A.,
RA   Skolnik E.Y.;
RT   "The phosphatidylinositol 3-phosphate phosphatase myotubularin-related
RT   protein 6 (MTMR6) is a negative regulator of the Ca2+-activated K+
RT   channel KCa3.1.";
RL   Mol. Cell. Biol. 25:3630-3638(2005).
RN   [9]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MTMR7; MTMR8 AND MTMR9.
RX   PubMed=16787938; DOI=10.1242/jcs.03040;
RA   Lorenzo O., Urbe S., Clague M.J.;
RT   "Systematic analysis of myotubularins: heteromeric interactions,
RT   subcellular localisation and endosome related functions.";
RL   J. Cell Sci. 119:2953-2959(2006).
RN   [10]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=16847315; DOI=10.1128/MCB.00352-06;
RA   Srivastava S., Ko K., Choudhury P., Li Z., Johnson A.K., Nadkarni V.,
RA   Unutmaz D., Coetzee W.A., Skolnik E.Y.;
RT   "Phosphatidylinositol-3 phosphatase myotubularin-related protein 6
RT   negatively regulates CD4 T cells.";
RL   Mol. Cell. Biol. 26:5595-5602(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561 AND SER-589, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M.,
RA   Meza-Zepeda L.A., Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561 AND SER-611, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-556 AND SER-561, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Phosphatase that acts on lipids with a phosphoinositol
CC       headgroup. Acts as a negative regulator of KCNN4/KCa3.1 channel
CC       activity in CD4+ T-cells possibly by decreasing intracellular
CC       levels of phosphatidylinositol 3 phosphatase. Negatively regulates
CC       proliferation of reactivated CD4+ T-cells.
CC       {ECO:0000269|PubMed:15831468, ECO:0000269|PubMed:16847315}.
CC   -!- SUBUNIT: Interacts with ALKBH4, KCNN4, MTMR7, MTMR8 and MTMR9.
CC       {ECO:0000269|PubMed:12890864, ECO:0000269|PubMed:15831468,
CC       ECO:0000269|PubMed:16787938, ECO:0000269|PubMed:23145062}.
CC   -!- INTERACTION:
CC       Q9Y2J4-4:AMOTL2; NbExp=3; IntAct=EBI-766064, EBI-10187270;
CC       Q96QG7:MTMR9; NbExp=8; IntAct=EBI-766064, EBI-744593;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-766064, EBI-742948;
CC       Q13287:NMI; NbExp=3; IntAct=EBI-766064, EBI-372942;
CC       Q8WTW2:NMI; NbExp=3; IntAct=EBI-766064, EBI-10174268;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-766064, EBI-719493;
CC   -!- SUBCELLULAR LOCATION: Nucleus envelope
CC       {ECO:0000269|PubMed:16787938}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y217-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y217-2; Sequence=VSP_036614, VSP_036615;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in CD4+ T-cells.
CC       {ECO:0000269|PubMed:16847315}.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Non-receptor class myotubularin subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF406619; AAL01037.1; -; mRNA.
DR   EMBL; AK093237; BAG52676.1; -; mRNA.
DR   EMBL; AK314587; BAG37162.1; -; mRNA.
DR   EMBL; AL832017; CAD89918.1; -; mRNA.
DR   EMBL; AL590787; CAI39897.1; -; Genomic_DNA.
DR   EMBL; BC040012; AAH40012.1; -; mRNA.
DR   EMBL; AF072928; AAC78841.1; -; mRNA.
DR   CCDS; CCDS9313.1; -. [Q9Y217-1]
DR   RefSeq; NP_004676.3; NM_004685.3. [Q9Y217-1]
DR   UniGene; Hs.643702; -.
DR   PDB; 2YF0; X-ray; 2.65 A; A=1-505.
DR   PDBsum; 2YF0; -.
DR   ProteinModelPortal; Q9Y217; -.
DR   SMR; Q9Y217; -.
DR   BioGrid; 114558; 21.
DR   IntAct; Q9Y217; 13.
DR   MINT; MINT-2822863; -.
DR   STRING; 9606.ENSP00000371221; -.
DR   SwissLipids; SLP:000001133; -.
DR   DEPOD; Q9Y217; -.
DR   iPTMnet; Q9Y217; -.
DR   PhosphoSitePlus; Q9Y217; -.
DR   BioMuta; MTMR6; -.
DR   DMDM; 317373414; -.
DR   EPD; Q9Y217; -.
DR   PaxDb; Q9Y217; -.
DR   PeptideAtlas; Q9Y217; -.
DR   PRIDE; Q9Y217; -.
DR   TopDownProteomics; Q9Y217-1; -. [Q9Y217-1]
DR   DNASU; 9107; -.
DR   Ensembl; ENST00000381801; ENSP00000371221; ENSG00000139505. [Q9Y217-1]
DR   GeneID; 9107; -.
DR   KEGG; hsa:9107; -.
DR   UCSC; uc001uqf.6; human. [Q9Y217-1]
DR   CTD; 9107; -.
DR   GeneCards; MTMR6; -.
DR   H-InvDB; HIX0011183; -.
DR   H-InvDB; HIX0171878; -.
DR   HGNC; HGNC:7453; MTMR6.
DR   MIM; 603561; gene.
DR   neXtProt; NX_Q9Y217; -.
DR   OpenTargets; ENSG00000139505; -.
DR   PharmGKB; PA31256; -.
DR   eggNOG; KOG1089; Eukaryota.
DR   eggNOG; ENOG410XPTU; LUCA.
DR   GeneTree; ENSGT00760000118832; -.
DR   HOVERGEN; HBG000220; -.
DR   InParanoid; Q9Y217; -.
DR   KO; K18083; -.
DR   OMA; IKFWRGM; -.
DR   OrthoDB; EOG091G02LA; -.
DR   PhylomeDB; Q9Y217; -.
DR   TreeFam; TF315197; -.
DR   BRENDA; 3.1.3.95; 2681.
DR   Reactome; R-HSA-1660499; Synthesis of PIPs at the plasma membrane.
DR   ChiTaRS; MTMR6; human.
DR   GeneWiki; MTMR6; -.
DR   GenomeRNAi; 9107; -.
DR   PRO; PR:Q9Y217; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   Bgee; ENSG00000139505; -.
DR   CleanEx; HS_MTMR6; -.
DR   Genevisible; Q9Y217; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:LIFEdb.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005635; C:nuclear envelope; IEA:UniProtKB-SubCell.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0052629; F:phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity; TAS:Reactome.
DR   GO; GO:0004438; F:phosphatidylinositol-3-phosphatase activity; TAS:Reactome.
DR   GO; GO:0004722; F:protein serine/threonine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; TAS:Reactome.
DR   GO; GO:0046856; P:phosphatidylinositol dephosphorylation; IEA:InterPro.
DR   GO; GO:0006470; P:protein dephosphorylation; NAS:UniProtKB.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR030581; MTMR6.
DR   InterPro; IPR010569; Myotubularin-like_Pase_dom.
DR   InterPro; IPR030564; Myotubularin_fam.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   PANTHER; PTHR10807; PTHR10807; 1.
DR   PANTHER; PTHR10807:SF103; PTHR10807:SF103; 1.
DR   Pfam; PF06602; Myotub-related; 1.
DR   SMART; SM00404; PTPc_motif; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS51339; PPASE_MYOTUBULARIN; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Hydrolase;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN         1    621       Myotubularin-related protein 6.
FT                                /FTId=PRO_0000094939.
FT   DOMAIN      124    499       Myotubularin phosphatase.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00669}.
FT   REGION      248    251       Substrate binding. {ECO:0000250}.
FT   REGION      273    274       Substrate binding. {ECO:0000250}.
FT   REGION      336    342       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    336    336       Phosphocysteine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10044}.
FT   BINDING     382    382       Substrate. {ECO:0000250}.
FT   MOD_RES     108    108       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:Q8VE11}.
FT   MOD_RES     556    556       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     561    561       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     589    589       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     611    611       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ     536    548       KIKQRKNKQTDGI -> LTSYSSFKIIVGQ (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036614.
FT   VAR_SEQ     549    621       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036615.
FT   VARIANT     131    131       A -> T (in dbSNP:rs34885345).
FT                                /FTId=VAR_057143.
FT   VARIANT     319    319       I -> V (in dbSNP:rs7995033).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:9736772,
FT                                ECO:0000269|Ref.2}.
FT                                /FTId=VAR_024583.
FT   CONFLICT     89     89       H -> R (in Ref. 4; CAD89918).
FT                                {ECO:0000305}.
FT   CONFLICT    114    114       P -> S (in Ref. 3; BAG37162).
FT                                {ECO:0000305}.
FT   CONFLICT    125    125       W -> R (in Ref. 4; CAD89918).
FT                                {ECO:0000305}.
FT   CONFLICT    333    333       L -> S (in Ref. 2; AAL01037 and 7;
FT                                AAC78841). {ECO:0000305}.
FT   CONFLICT    368    368       I -> T (in Ref. 3; BAG37162).
FT                                {ECO:0000305}.
FT   CONFLICT    430    430       H -> D (in Ref. 3; BAG52676).
FT                                {ECO:0000305}.
FT   CONFLICT    442    442       Q -> P (in Ref. 2; AAL01037 and 7;
FT                                AAC78841). {ECO:0000305}.
FT   STRAND        5     11       {ECO:0000244|PDB:2YF0}.
FT   STRAND       26     31       {ECO:0000244|PDB:2YF0}.
FT   STRAND       33     43       {ECO:0000244|PDB:2YF0}.
FT   STRAND       45     49       {ECO:0000244|PDB:2YF0}.
FT   HELIX        50     52       {ECO:0000244|PDB:2YF0}.
FT   STRAND       53     58       {ECO:0000244|PDB:2YF0}.
FT   STRAND       65     72       {ECO:0000244|PDB:2YF0}.
FT   STRAND       77     83       {ECO:0000244|PDB:2YF0}.
FT   HELIX        85     98       {ECO:0000244|PDB:2YF0}.
FT   HELIX       108    110       {ECO:0000244|PDB:2YF0}.
FT   HELIX       119    125       {ECO:0000244|PDB:2YF0}.
FT   HELIX       130    136       {ECO:0000244|PDB:2YF0}.
FT   STRAND      140    147       {ECO:0000244|PDB:2YF0}.
FT   HELIX       148    150       {ECO:0000244|PDB:2YF0}.
FT   STRAND      157    159       {ECO:0000244|PDB:2YF0}.
FT   STRAND      161    169       {ECO:0000244|PDB:2YF0}.
FT   HELIX       171    180       {ECO:0000244|PDB:2YF0}.
FT   HELIX       182    184       {ECO:0000244|PDB:2YF0}.
FT   STRAND      188    192       {ECO:0000244|PDB:2YF0}.
FT   TURN        194    196       {ECO:0000244|PDB:2YF0}.
FT   STRAND      199    202       {ECO:0000244|PDB:2YF0}.
FT   HELIX       215    227       {ECO:0000244|PDB:2YF0}.
FT   STRAND      234    238       {ECO:0000244|PDB:2YF0}.
FT   TURN        258    260       {ECO:0000244|PDB:2YF0}.
FT   STRAND      264    268       {ECO:0000244|PDB:2YF0}.
FT   HELIX       274    288       {ECO:0000244|PDB:2YF0}.
FT   HELIX       295    304       {ECO:0000244|PDB:2YF0}.
FT   HELIX       307    326       {ECO:0000244|PDB:2YF0}.
FT   STRAND      332    334       {ECO:0000244|PDB:2YF0}.
FT   TURN        336    338       {ECO:0000244|PDB:2YF0}.
FT   STRAND      339    341       {ECO:0000244|PDB:2YF0}.
FT   HELIX       342    354       {ECO:0000244|PDB:2YF0}.
FT   HELIX       357    359       {ECO:0000244|PDB:2YF0}.
FT   HELIX       361    371       {ECO:0000244|PDB:2YF0}.
FT   TURN        372    376       {ECO:0000244|PDB:2YF0}.
FT   HELIX       379    383       {ECO:0000244|PDB:2YF0}.
FT   STRAND      385    387       {ECO:0000244|PDB:2YF0}.
FT   HELIX       390    392       {ECO:0000244|PDB:2YF0}.
FT   HELIX       396    410       {ECO:0000244|PDB:2YF0}.
FT   TURN        412    414       {ECO:0000244|PDB:2YF0}.
FT   HELIX       419    429       {ECO:0000244|PDB:2YF0}.
FT   TURN        430    432       {ECO:0000244|PDB:2YF0}.
FT   STRAND      439    441       {ECO:0000244|PDB:2YF0}.
FT   HELIX       442    447       {ECO:0000244|PDB:2YF0}.
FT   HELIX       450    453       {ECO:0000244|PDB:2YF0}.
FT   HELIX       458    461       {ECO:0000244|PDB:2YF0}.
FT   HELIX       465    468       {ECO:0000244|PDB:2YF0}.
FT   STRAND      488    491       {ECO:0000244|PDB:2YF0}.
FT   HELIX       496    502       {ECO:0000244|PDB:2YF0}.
SQ   SEQUENCE   621 AA;  71968 MW;  1F34608F99DCEA39 CRC64;
     MEHIRTTKVE QVKLLDRFST SNKSLTGTLY LTATHLLFID SHQKETWILH HHIASVEKLA
     LTTSGCPLVI QCKNFRTVHF IVPRERDCHD IYNSLLQLSK QAKYEDLYAF SYNPKQNDSE
     RLQGWQLIDL AEEYKRMGVP NSHWQLSDAN RDYKICETYP RELYVPRIAS KPIIVGSSKF
     RSKGRFPVLS YYHQDKEAAI CRCSQPLSGF SARCLEDEHL LQAISKANPV NRYMYVMDTR
     PKLNAMANRA AGKGYENEDN YSNIRFQFVG IENIHVMRSS LQKLLEVNGT KGLSVNDFYS
     GLESSGWLRH IKAVMDAAIF LAKAITVENA SVLVHCSDGW DRTSQVCSLG SLLLDSYYRT
     IKGFMVLIEK DWISFGHKFS ERCGQLDGDP KEVSPVFTQF LECVWHLTEQ FPQAFEFSEA
     FLLQIHEHIH SCQFGNFLGN CQKEREELKL KEKTYSLWPF LLEDQKKYLN PLYSSESHRF
     TVLEPNTVSF NFKFWRNMYH QFDRTLHPRQ SVFNIIMNMN EQNKQLEKDI KDLESKIKQR
     KNKQTDGILT KELLHSVHPE SPNLKTSLCF KEQTLLPVND ALRTIEGSSP ADNRYSEYAE
     EFSKSEPAVV SLEYGVARMT C
//
